Notoginsenoside R1 Alleviates Acetaminophen-Induced Liver Injury via MAPK/mTOR-Mediated Autophagy.
What this study shows
Notoginsenoside R1 alleviates acetaminophen-induced acute liver injury by activating protective autophagy through MAPK/mTOR pathway modulation, reducing hepatocyte death and oxidative damage.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse |
| Journal | The American Journal of Chinese Medicine |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1142/S0192415X26500576 · PMID 42459050 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Notoginsenoside R1 |
| Target | MAPK/mTOR pathway; autophagy |
| Model | Mouse |
| Effect | NGR1 suppresses mTOR to activate autophagy, reducing APAP-induced hepatocyte apoptosis and liver injury |
In the Atlas
Related topics
More studies on this topic
- Molecular switches of SQSTM1: the impact of post-translational modifications on autophagy and neurodegeneration (2026)
- Strengthening Muscle for Healthy Ageing: Innovative Treatments for Sarcopenia (2026)
- Rapamycin alleviates toxicity of different aggregate-prone proteins (2006)
- Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster (2010)
Was this page useful?
Thank you. Your answer was counted anonymously.